[go: up one dir, main page]

SI1244643T1 - Tryptase inhibitors - Google Patents

Tryptase inhibitors

Info

Publication number
SI1244643T1
SI1244643T1 SI200030477T SI200030477T SI1244643T1 SI 1244643 T1 SI1244643 T1 SI 1244643T1 SI 200030477 T SI200030477 T SI 200030477T SI 200030477 T SI200030477 T SI 200030477T SI 1244643 T1 SI1244643 T1 SI 1244643T1
Authority
SI
Slovenia
Prior art keywords
tryptase inhibitors
inhibitors
tryptase
compounds
formula
Prior art date
Application number
SI200030477T
Other languages
English (en)
Slovenian (sl)
Inventor
Thomas Br
Josef Stadlwieser
Wolf-R�diger ULRICH
Andreas Dominik
Daniela Bundschuh
Karl Zech
Christian Sommerhoff
Thomas Martin
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1244643T1 publication Critical patent/SI1244643T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200030477T 1999-12-20 2000-12-16 Tryptase inhibitors SI1244643T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99125384 1999-12-20
EP00985174A EP1244643B1 (de) 1999-12-20 2000-12-16 Tryptase-inhibitoren
PCT/EP2000/012838 WO2001046168A1 (en) 1999-12-20 2000-12-16 Tryptase inhibitors

Publications (1)

Publication Number Publication Date
SI1244643T1 true SI1244643T1 (en) 2004-12-31

Family

ID=8239661

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030477T SI1244643T1 (en) 1999-12-20 2000-12-16 Tryptase inhibitors

Country Status (13)

Country Link
US (1) US7015325B2 (de)
EP (1) EP1244643B1 (de)
JP (1) JP2003518109A (de)
AT (1) ATE269313T1 (de)
AU (1) AU783217B2 (de)
CA (1) CA2392121A1 (de)
DE (1) DE60011677T2 (de)
DK (1) DK1244643T3 (de)
ES (1) ES2222259T3 (de)
PT (1) PT1244643E (de)
SI (1) SI1244643T1 (de)
TR (1) TR200402322T4 (de)
WO (1) WO2001046168A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273302T1 (de) 2001-01-31 2004-08-15 Altana Pharma Ag Diazocinderivate und deren verwendung als tryptase inhibitoren
DE60217076T2 (de) 2001-02-21 2007-06-21 Altana Pharma Ag Tryptaseinhibitoren
EP1363874B1 (de) 2001-02-21 2007-06-06 ALTANA Pharma AG Tryptasehemmer
JP2004525926A (ja) * 2001-03-15 2004-08-26 アルタナ　ファルマ　アクチエンゲゼルシャフト トリプターゼ阻害剤
WO2002074732A2 (en) * 2001-03-15 2002-09-26 Altana Pharma Ag Tryptase-inhibitors
DE60216920T2 (de) 2001-06-19 2007-11-15 Nycomed Gmbh Tryptase-inhibitoren
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds
JP7383483B2 (ja) 2017-03-29 2023-11-20 ミネルバ バイオテクノロジーズ コーポレーション 幹細胞を分化し、癌を処置するための作用薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999946A (en) * 1976-02-23 1976-12-28 Allied Chemical Corporation Time-temperature history indicators
US4228126A (en) * 1977-11-25 1980-10-14 Allied Chemical Corporation Diacetylene time-temperature indicators
US5656660A (en) * 1994-06-01 1997-08-12 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell mediated conditions
CN1160398A (zh) * 1994-09-23 1997-09-24 阿瑞斯药物公司 治疗肥大细胞炎性疾病的组合物和方法
EP0934293A1 (de) * 1996-07-30 1999-08-11 Arris Pharmaceutical Corporation Verbindungen und präparate für eine behandelung von krankheiten die mit tryptaseaktivität zusammenhangen
US6221914B1 (en) * 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
WO1999040083A2 (de) 1998-02-06 1999-08-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Bifunktionelle tryptase-inhibitoren
JP2002502845A (ja) 1998-02-06 2002-01-29 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ トリプターゼ阻害物質
EP1115731A2 (de) 1998-09-04 2001-07-18 Byk Gulden Lomberg Chemische Fabrik GmbH Neue pyranosen
CA2381919A1 (en) 1999-08-10 2001-02-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel tryptase inhibitors
WO2001019809A1 (en) 1999-09-14 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Tryptase inhibitors

Also Published As

Publication number Publication date
US7015325B2 (en) 2006-03-21
EP1244643A1 (de) 2002-10-02
EP1244643B1 (de) 2004-06-16
DK1244643T3 (da) 2004-10-18
JP2003518109A (ja) 2003-06-03
CA2392121A1 (en) 2001-06-28
ATE269313T1 (de) 2004-07-15
WO2001046168A1 (en) 2001-06-28
DE60011677T2 (de) 2005-07-14
TR200402322T4 (tr) 2004-12-21
ES2222259T3 (es) 2005-02-01
DE60011677D1 (en) 2004-07-22
US20030083344A1 (en) 2003-05-01
PT1244643E (pt) 2004-10-29
AU783217B2 (en) 2005-10-06
AU2166901A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
AU5414000A (en) Compounds
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
AU3328499A (en) Phthalazinone pde iii/iv inhibitors
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
NZ506329A (en) Inhibitors of phospholipase enzymes
MXPA02012271A (es) Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor.
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
GB9929552D0 (en) Compounds
MXPA03002911A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
MY133969A (en) Indoloquinazolinones
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
AP2001002220A0 (en) Calcilytic compounds.
DE60011677D1 (en) Tryptase-inhibitoren
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
SI1377574T1 (de)
AU6339000A (en) Serotonergic benzothiophenes
SI1244614T1 (en) Tryptase inhibitors
GB9923710D0 (en) Chemical compounds
DE60216920D1 (en) Tryptase-inhibitoren
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
DE60220504D1 (en) Tryptasehemmer
AU6832498A (en) Substituted benzyl oximino compounds
SI1358182T1 (en) Diazocine derivates and their use as tryptase inhibitors
DE60217076D1 (en) Tryptaseinhibitoren